期刊文献+

人类免疫缺陷病毒感染与代谢异常的临床研究 被引量:2

Clinical study on human immunodeficiency virus infection and metabolic disturbance
下载PDF
导出
摘要 目的 探讨人类免疫缺陷病毒(HIV)感染患者是否有血糖、血脂、尿酸等代谢指标异常以及与CD4细胞计数的关系.方法 根据国家2004年制订的获得性免疫缺陷综合征诊疗指南标准,入选HIV感染的患者为云南省传染病关爱中心2010年3~9月门诊和住院患者及德宏州陇川县HIV感染患者,共220例作为观察组,另选取昆明医学院第二附属医院2010年9~10月健康体检者182例为健康对照组.对所有研究对象均进行血脂、血糖、肾功能、CD4的测定.结果 代谢指标异常以低血糖多见及高三酰甘油,低胆固醇为主.随着CD4值的下降,胆固醇、三酰甘油随之下降.结论 HIV感染患者存在代谢指标的异常,血脂的变化与CD4值有相关性. Objective To explore whether there is abnormality of metabolic indicators like blood glucose,serum lipid and uric aeid(UA) in human immunodeficiency virus (HIV)-infeeted adults,and to observe the possible relationship between metabolic and CD4 cell counts. Methods According to the 2004 HIV infection developed diagnostic criteria and exclusion crite- ria,220 HIV-infected patients,who were hospitalized in Yunnan Provincial Care Center of Infection from March to September 2010 and from Longchuan county of Dehong, were regarded as observation group, while 182 healthy subjects in the second affiliat- ed hospital of Kunming Medical College from September to October 2010 were taken as healthy control group. The serum lipid, blood glucose,renal function and CD4 in all subjects were determined. Results Metabolic indicators abnormality mainly concen trated on hypoglycemia, triglyceride (TC) and low cholesterol. The cholesterol and triacylglycerol (TG) decrease along with decline of CD~ cell counts. Conclusion HIV-infected patients have metabolic abnormality, and the change of serum lipid is related to CD4 cell counts.
出处 《现代医药卫生》 2014年第4期488-489,492,共3页 Journal of Modern Medicine & Health
关键词 HIV感染 代谢疾病 CD4淋巴细胞计数 获得性免疫缺陷综合征 H1V infection Metabolic diseases CD4 lymphocyte count Acquired immunodeficiency syndrome
  • 相关文献

参考文献11

  • 1马建新,卢洪洲.HIV感染及治疗过程中代谢紊乱的诊断与治疗进展[J].中国艾滋病性病,2007,13(5):492-494. 被引量:13
  • 2Grinspoon S,Carr A. Cardiovascular risk and body-fat abnorma-lities in HIV-infected adults[J].{H}New England Journal of Medicine,2005,(01):48-62. 被引量:1
  • 3Tsiodras S,Mantzoros C. Leptin and adiponectin in the HIV asso-ciated metabolic syndrome:physiologic and therapeutic implica-tions[J].Am J Infect Dis,2006,(03):141-152. 被引量:1
  • 4Hadigan C,Kamin D,Liebau J. Depot-specific regulation of glucose uptake and insulin sensitivity in HIV-lipodystrophy[J].{H}American Journal of Physiology Endocrinology and Metabolism,2006,(02):E289-E298. 被引量:1
  • 5Sattler FR,Schroeder ET,Dube MP. Metabolic effects of nandrolone decanoate and resistance training in men with HIV[J].{H}American Journal of Physiology Endocrinology and Metabolism,2002,(06):E1214-E1222. 被引量:1
  • 6Brown TT,Cole SR,Li X. Antiretroviral therapy and the pre-valence and incidence of diabetes mellitus in the multicenter AIDS cohort study[J].{H}Archives of Internal Medicine,2005,(10):1179-1184. 被引量:1
  • 7Behrens GM. Cardiovascular risk and body-fat abnormalities in HIV-infected adults[J].{H}New England Journal of Medicine,2005,(16):1721-1762. 被引量:1
  • 8Hansen AB,Lindegaard B,Obel N. Pronounced lipoatrophy in HIV-infected men receiving HAART for more than 6 years compared with the background population[J].{H}HIV MEDICINE,2006,(01):38-45. 被引量:1
  • 9Beltran S,Lescure FX,El Esper I. Subclinical hypothyroi-dism in HIV-infected patients is not an autoimmune disease[J].{H}Hormone Research,2006,(01):21-26. 被引量:1
  • 10Kino T,De Martino MU,Charmandari E. HIV-1 accessory protein Vpr inhibits the effect of insulin on the Foxo subfamily of forkhead transcription factors by interfering with their binding to 14-3-3 proteins:potential clinical implications regarding the in-sulin resistance of HIV-1-infected patients[J].{H}DIABETES,2005,(01):23-31. 被引量:1

二级参考文献20

  • 1Bacchetti P, Gripshover B, Grunfeld C, et al. Fat Distribution in men with HIV infection[J] .J Acquir Immune Defic Syndr, 2005,40:121 -31. 被引量:1
  • 2From the Study of Fat Redistribution and Metabolic Change in HIV Infection(FRAN)Fat distribution in Women with HIV Infection[J] .J Acquir Immune Defic Syndr, 2006,42(5) :562 -571. 被引量:1
  • 3AB Hansen, B Lindegaard, NObel, et al.Pronounced lipoatrophy in HIV- infected men receiving HAART for more than 6 years compared with the background population [ J ] . HIV Medicine, 2006,7: 38 -45. 被引量:1
  • 4Grinspoon S, Carr A. Cardiovascular risk and body-fat abnormalities in HIV-infected adults[ J ]. N Engl J Med, 2005,352 : 48 - 62. 被引量:1
  • 5McCornsey GA, Ward DJ, Hessenthaler SM, et al. Improvement in lipoatrophy associated with highly active antiretroviral therapy in human imrnunodeficiency virus-infected patients switched from stavudine to ahacavlr or zidovudine: the results of the TARHEEL study[J]. Clin Infect Dis, 2004,38 : 263 - 270. 被引量:1
  • 6Barragan P, Fisac C, Podzamczer D.Switching strategies to improve lipid profile and morphologic changes[J].AIDS Rev,2006,8 (4) : 191 -203. 被引量:1
  • 7Hadigan C,Yawetz S, Thomas A, et al. Metabolic effects of rosiglitazone in HIV lipodystrophy: a randomized, controlled trial[ J ]. Ann Intern Med, 2004,140:786-794. 被引量:1
  • 8O Lopez, D Bonnefont-Rousselot, M Edeas, et al.could antioxidant supplementation reduce antiretroviral therapy-induced chronic stable hyperlactatemia? [J].Biomedicine & Pharmacotherapy, 2003,57: 113 - 116. 被引量:1
  • 9E Funk,F J Bressler, A E Brissett, et al. Contemporary surgical management of HIV-associated facial lipoatrophy [ J ] .Otolaryngology-Head and Neck Surgery, 2006,134 : 1015 - 1022. 被引量:1
  • 10Sax PE, Kumar P. Tolerability and safety of HIV protease inhibitors in adults[J] .J Acquit Immune Defie Syndr, 2004,37:1111- 24. 被引量:1

共引文献12

同被引文献17

引证文献2

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部